Genome Editing/Genome Engineering technique are used for insertion, deletion or modify genome of a microorganism. Techniques like TALEN, CRISPR (clustered regularly interspaced palindromic repeat) and other technique are widely used in genome editing/engineering process. CRISPR-Cas9 technique is one of the most widely preferred technologies in genome editing. The global genome editing/genome engineering market is driven by technological advancements in the genomics, rising number of cancer patients, and increasing funding by government & private players in the genomics are major factors driving the market. However, ethical issue related to genome editing/genome engineering is likely to restrain the market to certain extent.
Market Industry Reports (MIR) has published a new report titled "Genome Editing/Genome Engeineering Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030." According to the report the global genome editing market was valued at over US$ 3.0 Bn. in 2017 and is anticipated to grow at a CAGR of 14.1% from 2019 to 2030. The growth of this market can be attributed to the major factor that is utilization of the technique for therapeutic genetic editing in infected tissues and cells, thereby reducing the mutations.
Major Key Players of the Genome Editing/Genome Engineering Market are:Thermo Fisher Scientific (US), Lonza Group (Switzerland), Merck (Germany), Horizon Discovery Group (UK), Integrated DNA Technologies (US), New England Biolabs (US), GenScript (US), Sangamo BioSciences (US), OriGene Technologies (US), Transposagen Biopharmaceuticals (US), Editas Medicine (US), and CRISPR Therapeutics (Switzerland)., among others.
No comments:
Post a Comment